Mutational analysis of breast cancer: guiding personalized treatments
about
Analysis of different HER-2 mutations in breast cancer progression and drug resistancePatient-derived xenograft models of breast cancer and their predictive powerMetastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General HospitalThe side effects of translational omics: overtesting, overdiagnosis, overtreatment.
P2860
Mutational analysis of breast cancer: guiding personalized treatments
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mutational analysis of breast cancer: guiding personalized treatments
@en
Mutational analysis of breast cancer: guiding personalized treatments.
@nl
type
label
Mutational analysis of breast cancer: guiding personalized treatments
@en
Mutational analysis of breast cancer: guiding personalized treatments.
@nl
prefLabel
Mutational analysis of breast cancer: guiding personalized treatments
@en
Mutational analysis of breast cancer: guiding personalized treatments.
@nl
P2860
P1433
P1476
Mutational analysis of breast cancer: guiding personalized treatments
@en
P2093
Matthew J Ellis
P2860
P304
P356
10.1016/J.BREAST.2013.07.003
P478
22 Suppl 2
P577
2013-08-01T00:00:00Z